Want to join the conversation?
$HSP General Update: Obtained U.S. FDA approval for launch of bivalirudin for injection, a generic version of The Medicines Company's Angiomax. Branded sales of Angiomax in 2014 in the United States were approximately $500MM.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.